Association Between Reduced Plasma 25-Hydroxy Vitamin D and Increased Risk of Cancer in Patients With Inflammatory Bowel Diseases Ashwin N. Ananthakrishnan, Su–Chun Cheng, Tianxi Cai, Andrew Cagan, Vivian S. Gainer, Peter Szolovits, Stanley Y. Shaw, Susanne Churchill, Elizabeth W. Karlson, Shawn N. Murphy, Isaac Kohane, Katherine P. Liao Clinical Gastroenterology and Hepatology Volume 12, Issue 5, Pages 821-827 (May 2014) DOI: 10.1016/j.cgh.2013.10.011 Copyright © 2014 AGA Institute Terms and Conditions
Figure 1 Plasma 25(OH)D levels in patients, stratified by subsequent diagnosis of cancer. Clinical Gastroenterology and Hepatology 2014 12, 821-827DOI: (10.1016/j.cgh.2013.10.011) Copyright © 2014 AGA Institute Terms and Conditions
Figure 2 Plasma 25(OH)D levels in patients, stratified by subsequent diagnosis of colorectal cancer. Clinical Gastroenterology and Hepatology 2014 12, 821-827DOI: (10.1016/j.cgh.2013.10.011) Copyright © 2014 AGA Institute Terms and Conditions